Hirasawa, 2018 [14]
|
RCT
|
45/45
|
PAI, no PAI
|
GA
|
Rop 300 mg, Mor 8 mg, Methyl 40 mg, Keto 50 mg, Epi 0.3 mg
|
V
| |
V
| | | |
5
|
Ban WR,2017 [5]
|
RCT
|
43/43
|
PAI, no PAI
|
GA
|
Rop200mg, Keto 30 mg, Epi 0.3 mg
|
V
| |
V
| |
V
| |
5
|
Villatte, 2016 [6]
|
RCT
|
75/75
|
PAI, no PAI
|
GA
|
Rop 235 mg, Epi 0.5 mg
|
V
| |
V
| |
V
| |
5
|
Hofstad, 2015 [10]
|
RCT
|
55/54
|
PAI, no PAI
|
SA
|
Rop 300 mg, Epi 0.5 mg
| | | |
V
|
V
| |
5
|
den Hartog, 2015 [11]
|
RCT
|
25/25
|
PAI, no PAI
|
SA
|
Rop 200 mg, Epi 0.5 mg
| | | | |
V
|
V
|
5
|
Zoric, 2014 [12]
|
RCT
|
29/29
|
PAI, no PAI
|
GA
|
Rop 160 mg
| | |
V
|
V
| |
V
|
4
|
Dobie, 2012 [15]
|
RCT
|
46/46
|
PAI, no PAI
|
GA
|
Levo 160 mg
|
V
| | | |
V
| |
5
|
Murphy, 2012 [7]
|
RCT
|
45/46
|
PAI, no PAI
|
SA
|
Bup 150 mg
|
V
| |
V
|
V
| | |
5
|
Lunn, 2011 [13]
|
RCT
|
60/60
|
PAI, no PAI
|
SA
|
Rop 200 mg, Epi 1.5 mg
| | | | |
V
| |
5
|
Liu, 2011 [8]
|
RCT
|
40/40
|
PAI, no PAI
|
SA
|
Bup 30 mg, Mor 5 mg, Bet 1 mg, Epi 0.5 mg
|
V
| | | | |
V
|
5
|
Busch, 2010 [9]
|
RCT
|
32/31
|
PAI, no PAI
|
SA or GA
|
Rop 40 mg, Keto 30 mg, Epi 0.5 mg
|
V
| | | | | |
4
|